Literature DB >> 18510654

Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models.

B Rosner1, R J Glynn.   

Abstract

The Wilcoxon Mann-Whitney (WMW) U test is commonly used in nonparametric two-group comparisons when the normality of the underlying distribution is questionable. There has been some previous work on estimating power based on this procedure (Lehmann, 1998, Nonparametrics). In this article, we present an approach for estimating type II error, which is applicable to any continuous distribution, and also extend the approach to handle grouped continuous data allowing for ties. We apply these results to obtaining standard errors of the area under the receiver operating characteristic curve (AUROC) for risk-prediction rules under H(1) and for comparing AUROC between competing risk prediction rules applied to the same data set. These results are based on SAS-callable functions to evaluate the bivariate normal integral and are thus easily implemented with standard software.

Entities:  

Mesh:

Year:  2008        PMID: 18510654     DOI: 10.1111/j.1541-0420.2008.01062.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  36 in total

1.  Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations.

Authors:  Roland A Matsouaka; Rebecca A Betensky
Journal:  Stat Med       Date:  2014-11-13       Impact factor: 2.373

2.  Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.

Authors:  Johanna M Seddon; Robyn Reynolds; Yi Yu; Mark J Daly; Bernard Rosner
Journal:  Ophthalmology       Date:  2011-09-29       Impact factor: 12.079

3.  Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion.

Authors:  Rulla M Tamimi; Bernard Rosner; Graham A Colditz
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

4.  Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model.

Authors:  Megan S Rice; Shelley S Tworoger; Susan E Hankinson; Rulla M Tamimi; A Heather Eliassen; Walter C Willett; Graham Colditz; Bernard Rosner
Journal:  Breast Cancer Res Treat       Date:  2017-07-12       Impact factor: 4.872

5.  Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates.

Authors:  Johanna M Seddon; Rachel E Silver; Manlik Kwong; Bernard Rosner
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

6.  The benefits of using genetic information to design prevention trials.

Authors:  Youna Hu; Li Li; Margaret G Ehm; Nan Bing; Kijoung Song; Matthew R Nelson; Philippa J Talmud; Aroon D Hingorani; Meena Kumari; Mika Kivimäki; Chun-Fang Xu; Dawn M Waterworth; John C Whittaker; Gonçalo R Abecasis; Cathie Spino; Hyun Min Kang
Journal:  Am J Hum Genet       Date:  2013-03-28       Impact factor: 11.025

7.  Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy.

Authors:  Kana Wu; Edward L Giovannucci; Yin Cao; Bernard A Rosner; Jing Ma; Rulla M Tamimi; Andrew T Chan; Charles S Fuchs
Journal:  Int J Cancer       Date:  2015-04-23       Impact factor: 7.396

8.  Lipoprotein subclass abnormalities and incident hypertension in initially healthy women.

Authors:  Nina P Paynter; Howard D Sesso; David Conen; James D Otvos; Samia Mora
Journal:  Clin Chem       Date:  2011-06-23       Impact factor: 8.327

9.  Comparison of Performance Between a Short Categorized Lifestyle Exposure-based Colon Cancer Risk Prediction Tool and a Model Using Continuous Measures.

Authors:  Ying Liu; Graham A Colditz; Bernard A Rosner; Hank Dart; Esther Wei; Erika A Waters
Journal:  Cancer Prev Res (Phila)       Date:  2018-11-16

10.  A Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses' Health Study.

Authors:  Esther K Wei; Graham A Colditz; Edward L Giovannucci; Kana Wu; Robert J Glynn; Charles S Fuchs; Meir Stampfer; Walter Willett; Shuji Ogino; Bernard Rosner
Journal:  Am J Epidemiol       Date:  2017-02-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.